{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:13:17Z","timestamp":1744171997429,"version":"3.40.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1245\/s10434-025-16985-8","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:10:46Z","timestamp":1739477446000},"page":"3292-3301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI"],"prefix":"10.1245","volume":"32","author":[{"given":"B. Bersu","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firouzeh K.","family":"Arjmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dogan S.","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunati","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Leitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-093X","authenticated-orcid":false,"given":"Basak E.","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"16985_CR1","unstructured":"American Cancer Society: Cancer Facts and Figures 2023. American Cancer Society, 2023. Available online. url: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2023-cancer-facts-figures.html. Last accessed Dec 24, 2023."},{"key":"16985_CR2","first-page":"732","volume":"237","author":"SW Beenken","year":"2003","unstructured":"Beenken SW, Urist MM, Zhang Y, et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg. 2003;237:732\u20139.","journal-title":"Ann Surg"},{"key":"16985_CR3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg. 2014;260:608\u201314.","journal-title":"Ann Surg"},{"key":"16985_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.seminoncol.2020.09.001","volume":"47","author":"F Magnoni","year":"2020","unstructured":"Magnoni F, Galimberti V, Corso G, Intra M, Sacchini V, Veronesi P. Axillary surgery in breast cancer: an updated historical perspective. Semin Oncol. 2020;47:341\u201352.","journal-title":"Semin Oncol"},{"key":"16985_CR5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection versus no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918\u201326.","journal-title":"JAMA"},{"key":"16985_CR6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546\u201353.","journal-title":"N Engl J Med."},{"issue":"10","key":"16985_CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"key":"16985_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","volume":"13","author":"LG Wilke","year":"2006","unstructured":"Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491\u2013500. https:\/\/doi.org\/10.1245\/ASO.2006.05.013.","journal-title":"Ann Surg Oncol"},{"key":"16985_CR9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500\u201315.","journal-title":"Lancet Oncol"},{"key":"16985_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1213\/00000539-200208000-00026","volume":"95","author":"LL Montgomery","year":"2002","unstructured":"Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385\u20138.","journal-title":"Anesth Analg"},{"issue":"2","key":"16985_CR11","first-page":"169","volume":"12","author":"RA Sacre","year":"1986","unstructured":"Sacre RA. Clinical evaluation of axillar lymph nodes compared to surgicaland pathological findings. Eur J Surg Oncol. 1986;12(2):169\u201373.","journal-title":"Eur J Surg Oncol"},{"key":"16985_CR12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, McCall LM, Hunt KK, et al. Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol. 2018;210:669\u201376.","journal-title":"AJR Am J Roentgenol"},{"key":"16985_CR13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jbi\/wbab082","volume":"3","author":"V Dialani","year":"2021","unstructured":"Dialani V, Dogan B, Dodelzon K, Dontchos BN, Modi N, Grimm L. Axillary imaging following a new invasive breast cancer diagnosis\u2014a radiologist\u2019s dilemma. J Breast Imag. 2021;3:645\u201358.","journal-title":"J Breast Imag"},{"issue":"1","key":"16985_CR14","doi-asserted-by":"publisher","first-page":"znad401","DOI":"10.1093\/bjs\/znad401","volume":"111","author":"AM Zaborowski","year":"2024","unstructured":"Zaborowski AM, Doogan K, Clifford S, et al. Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative study. Br J Surg. 2024;111(1):znad401. https:\/\/doi.org\/10.1093\/bjs\/znad401.","journal-title":"Br J Surg"},{"issue":"18","key":"16985_CR15","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.3390\/cancers14184451","volume":"14","author":"CC Yu","year":"2022","unstructured":"Yu CC, Cheung YC, Ueng SH, et al. Factors associated with axillary lymph node status in clinically node-negative breast cancer patients undergoing neoadjuvant chemotherapy. Cancers (Basel). 2022;14(18):4451.","journal-title":"Cancers (Basel)"},{"key":"16985_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"16985_CR17","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. College of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.","journal-title":"J Clin Oncol"},{"issue":"10","key":"16985_CR18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","volume":"32","author":"HJ Burstein","year":"2021","unstructured":"Burstein HJ, Curigliano G, Th\u00fcrlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32(10):1216\u201335.","journal-title":"Ann Oncol"},{"issue":"1","key":"16985_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"key":"16985_CR20","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1245\/s10434-014-3851-y","volume":"21","author":"S Ugras","year":"2014","unstructured":"Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014;21:3780\u20136. https:\/\/doi.org\/10.1245\/s10434-014-3851-y.","journal-title":"Ann Surg Oncol"},{"key":"16985_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/radiol.10100296","volume":"257","author":"CH Neal","year":"2010","unstructured":"Neal CH, Daly CP, Nees AV, Helvie MA. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? Radiology. 2010;257:335\u201341.","journal-title":"Radiology"},{"key":"16985_CR22","unstructured":"Avoiding sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy (ASICS). ClinicalTrials.gov Identifier: NCT04225858. Updated January 13, 2020. Accessed May 26, 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04225858"},{"key":"16985_CR23","unstructured":"Omission of SLNB in Triple-negative and HER2-positive breast cancer patients with rCR and pCR in the breast after NAST (EUBREAST-01). ClinicalTrials.gov Identifier: NCT04101851. Updated May 12, 2023. Accessed on May 26, 2023 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04101851"},{"key":"16985_CR24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S1470-2045(22)00613-1","volume":"23","author":"HM Kuerer","year":"2022","unstructured":"Kuerer HM, Smith BD, Krishnamurthy S, et al. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2022;23:1517\u201324.","journal-title":"Lancet Oncol"},{"key":"16985_CR25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/SLA.0000000000002313","volume":"267","author":"HM Kuerer","year":"2018","unstructured":"Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2018;267:946.","journal-title":"Ann Surg"},{"key":"16985_CR26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jso.23790","volume":"111","author":"CS Connor","year":"2015","unstructured":"Connor CS, Kimler BF, Mammen JM, et al. Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer. J Surg Oncol. 2015;111:198\u2013202.","journal-title":"J Surg Oncol"},{"key":"16985_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jso.24034","volume":"112","author":"Z Al-Hilli","year":"2015","unstructured":"Al-Hilli Z, Hieken TJ, Hoskin TL, Heins CN, Boughey JC. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease. J Surg Oncol. 2015;112:453\u20137.","journal-title":"J Surg Oncol"},{"key":"16985_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cncr.23130","volume":"112","author":"JH Chen","year":"2008","unstructured":"Chen JH, Feig B, Agrawal G, et al. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008;112:17\u201326.","journal-title":"Cancer"},{"key":"16985_CR29","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1245\/s10434-011-1912-z","volume":"18","author":"KP McGuire","year":"2011","unstructured":"McGuire KP, Toro-Burguete J, Dang H, et al. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? Ann Surg Oncol. 2011;18:3149\u201354. https:\/\/doi.org\/10.1245\/s10434-011-1912-z.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"16985_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10549-020-06047-w","volume":"185","author":"K Schumacher","year":"2021","unstructured":"Schumacher K, Inciardi M, O\u2019Neil M, et al. Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging? Breast Cancer Res Treat. 2021;185(3):567\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"16985_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2214\/AJR.21.26135","volume":"218","author":"HL Chung","year":"2022","unstructured":"Chung HL, Tso HH, Middleton LP, Sun J, Leung JWT. Axillary nodal metastases in invasive lobular carcinoma versus invasive ductal carcinoma: comparison of node detection and morphology by ultrasound. AJR Am J Roentgenol. 2022;218(1):33\u201341.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"16985_CR32","doi-asserted-by":"crossref","first-page":"e230107","DOI":"10.1148\/rycan.230107","volume":"6","author":"DS Polat","year":"2024","unstructured":"Polat DS, Nguyen S, Karbasi P, et al. Machine learning prediction of lymph node metastasis in breast cancer: performance of a multi-institutional MRI-based 4D convolutional neural network. Radiol Imaging Cancer. 2024;6(3):e230107.","journal-title":"Radiol Imaging Cancer"},{"issue":"2","key":"16985_CR33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4274\/ejbh.galenos.2024.2023-12-12","volume":"20","author":"DS Polat","year":"2024","unstructured":"Polat DS, Xi Y, Hulsey K, Lewis M, Dogan BE. radiomics analysis of contrast-enhanced breast mri for optimized modelling of virtual prognostic biomarkers in breast cancer. Eur J Breast Health. 2024;20(2):122\u20138.","journal-title":"Eur J Breast Health"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16985-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:25:24Z","timestamp":1744097124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16985-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16985"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16985-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}